Market Newsdesk

February 6, 2025 5:52 am

RIG LAWSUIT ALERT: The Gross Law Firm Notifies Transocean Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Transocean Ltd. (NYSE: RIG).

Shareholders who purchased shares of RIG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/transocean-ltd-loss-submission-form/?id=127266&from=4

CLASS PERIOD:
October 31, 2023 to September 2, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the oil rigs Discoverer Inspiration and Development Driller III were considered non-strategic assets; (2) the Company’s recorded asset valuations were overstated; (3) as a result, the Company would take nearly twice the vessels’ sale price in impairment if sold; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: February 24, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/transocean-ltd-loss-submission-form/?id=127266&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RIG during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 24, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/rig-lawsuit-alert-the-gross-law-firm-notifies-transocean-ltd-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302369547.html

SOURCE The Gross Law Firm

February 6, 2025 5:52 am

The Gross Law Firm Notifies Shareholders of Revance Therapeutics, Inc.(RVNC) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC).

Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/revance-therapeutics-inc-loss-submission-form-2/?id=127269&from=4

CLASS PERIOD:
February 29, 2024 to December 6, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Revance was in material breach of the Distribution Agreement with Teoxane, which granted Revance “the exclusive right to import, market, promote, sell and distribute Teoxane’s line of dermal fillers; (ii) the foregoing subjected the Company to an increased risk of litigation, as well as monetary and reputational harm; (iii) all the foregoing increased the risk that the tender offer would be delayed and/or amended; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: March 4, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/revance-therapeutics-inc-loss-submission-form-2/?id=127269&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RVNC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 4, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-revance-therapeutics-incrvnc-of-a-class-action-lawsuit-and-an-upcoming-deadline-302369534.html

SOURCE The Gross Law Firm

February 6, 2025 5:52 am

Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action – CRBU

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU).

Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/caribou-biosciences-inc-loss-submission-form/?id=127267&from=4

CLASS PERIOD:
July 14, 2023 to July 16, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) they had overstated CB-010’s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r/r B-NHL and/or LBCL, as well as CB-010’s overall clinical results and commercial prospects; (ii) Caribou was at significant risk of having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; (iii) all the foregoing was likely to have a significant negative impact on Caribou’s business and operations; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: February 24, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/caribou-biosciences-inc-loss-submission-form/?id=127267&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CRBU during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 24, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/investors-who-lost-money-on-caribou-biosciences-inccrbu-should-contact-the-gross-law-firm-about-pending-class-action—crbu-302369527.html

SOURCE The Gross Law Firm

February 6, 2025 5:51 am

WBA LAWSUIT ALERT: The Gross Law Firm Notifies Walgreens Boots Alliance, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).

Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=127285&from=4

CLASS PERIOD:
April 2, 2020 to January 16, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company’s purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens’ revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: March 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=127285&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of WBA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 31, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/wba-lawsuit-alert-the-gross-law-firm-notifies-walgreens-boots-alliance-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302369553.html

SOURCE The Gross Law Firm

February 6, 2025 5:51 am

The Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline – AZN

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN).

Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
February 23, 2022 to December 17, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca’s business activities in China; and (5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: February 21, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/astrazeneca-plc-loss-submission-form-2/?id=127264&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of AZN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is February 21, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-astrazeneca-plc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–azn-302369540.html

SOURCE The Gross Law Firm

February 6, 2025 5:51 am

Shareholders that lost money on Newmont Corporation(NEM) should contact The Gross Law Firm about pending Class Action – NEM

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Newmont Corporation (NYSE: NEM).

Shareholders who purchased shares of NEM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/newmont-corporation-loss-submission-form/?id=127286&from=4

CLASS PERIOD:
February 22, 2024 to October 23, 2024

ALLEGATIONS: According to the complaint, on October 23, 2024, Newmont published a press release announcing disappointing EBITDA third quarter 2024 highlights, in addition to decreases in production and increases in operating costs. In pertinent part, Newmont revealed that mining operations at its two Tier 1 assets would see lower production than originally guided with expectations of higher costs at these facilities. Following this news, Newmont’s stock price fell from a closing market price of $57.74 per share on October 23, 2024 to $49.25 per share on October 24, 2024.

DEADLINE: April 1, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/newmont-corporation-loss-submission-form/?id=127286&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NEM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 1, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-newmont-corporationnem-should-contact-the-gross-law-firm-about-pending-class-action—nem-302369568.html

SOURCE The Gross Law Firm

February 6, 2025 5:51 am

The Gross Law Firm Notifies Shareholders of Crocs, Inc.(CROX) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Crocs, Inc. (NASDAQ: CROX).

Shareholders who purchased shares of CROX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/crocs-inc-loss-submission-form/?id=127277&from=4

CLASS PERIOD:
November 3, 2022 to October 28, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the nature and sustainability of footwear brand, HEYDUDE’s revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Company’s efforts to stock third-party wholesalers and retailers following the February 2022 acquisition of HEYDUDE; (2) as the Company’s retail partners began to destock this excess inventory, waning product demand further negatively impacted the Company’s financial results; and (3) as a result, defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

DEADLINE: March 24, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/crocs-inc-loss-submission-form/?id=127277&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CROX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 24, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-crocs-inccrox-of-a-class-action-lawsuit-and-an-upcoming-deadline-302369567.html

SOURCE The Gross Law Firm

February 6, 2025 5:51 am

The Gross Law Firm Notifies TELUS International (Cda) Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TIXT

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of TELUS International (Cda) Inc. (NYSE: TIXT).

Shareholders who purchased shares of TIXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
February 16, 2023 to August 1, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s AI Data Solutions offerings required the cannibalization of its higher-margin offerings; (2) Telus International’s declining profitability was tied to the Company’s drive to develop AI capabilities; (3) Telus International’s shift toward AI put greater pressure on the Company’s margins than previously disclosed; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: March 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/telus-international-loss-submission-form/?id=127284&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TIXT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 31, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-telus-international-cda-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–tixt-302369549.html

SOURCE The Gross Law Firm

February 6, 2025 5:50 am

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 18, 2025 in Block, Inc. Lawsuit – XYZ

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Block, Inc. (NYSE: XYZ).

Shareholders who purchased shares of XYZ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD:
February 26, 2020 to April 30, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) Block had engaged in widespread and years-long compliance lapses at Square and Cash App, including by failing to conduct basic due diligence regarding its customers’ identities or the nature of customer transactions so as to prevent the platforms from being used for illegal or illicit activities; (b) Block had effectively created a haven for widespread illegal and illicit activities on its Square and Cash App platforms by imposing minimal obligations on customers seeking to open accounts, transact, and deposit or withdraw funds; encouraging the use of bitcoin; and pressuring the Company’s banking partners to forgo ordinary know your customer due diligence activities; (c) thousands of transactions on Square and Cash App were made in connection with a wide variety of illegal and illicit activities, including, inter alia, money laundering, child sexual abuse, sex trafficking, drug trafficking, terrorism financing, contract killings, and illicit payments to entities and persons subject to economic sanctions; (d) Block allowed its customers to withdraw funds even after the accounts had been flagged for potentially illegal or illicit activities; (e) Block customers could open up multiple accounts using fake identities in order to engage in illegal or illicit activities; (e) Block customers could open up multiple accounts using fake identities in order to engage in illegal or illicit activities; (f) Block’s senior leadership and the Board had failed to correct identified compliance deficiencies despite numerous red flags, internal employee reports of deficiencies, and customer complaints; (g) Block’s Cash App user metrics had been artificially inflated through the use of fake accounts and the ability of criminals and other bad actors to open multiple accounts; and (h), as a result of (a)-(g) above, Block was subject to a material, undisclosed risk of its conduct being exposed, thereby exposing the Company to reputational harm, adverse regulatory actions, the loss of business activity, and adverse impacts to the Company’s operations and financial results.

DEADLINE: March 18, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/block-inc-loss-submission-form/?id=127274&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of XYZ during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 18, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-march-18-2025-in-block-inc-lawsuit–xyz-302369551.html

SOURCE The Gross Law Firm

February 6, 2025 5:50 am

The Gross Law Firm Reminds Innovative Industrial Properties Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 18, 2025 – IIPR

PR Newswire

NEW YORK
, Feb. 6, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR).

Shareholders who purchased shares of IIPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/innovative-industrial-properties-inc-loss-submission-form-2/?id=127275&from=4

CLASS PERIOD:
February 27, 2024 to December 19, 2024

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) IIPR was experiencing significant declines in rent and property-management fees in connection with certain customer leases; (ii) the foregoing would likely impair the Company’s ability to maintain funds from operations and revenue growth; (iii) accordingly, IIPR’s leasing operations were less profitable than the Company had represented to investors; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of IIPR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 18, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-innovative-industrial-properties-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-march-18-2025–iipr-302369563.html

SOURCE The Gross Law Firm